The North America Cancer Biomarkers Market would witness Market growth of 15.4% CAGR during the forecast period (2022-2028).
Cancer biomarkers are biological compounds produced by tumor cells or human tissues in response to cancer, which is then evaluated and investigated as signs of malignant activity in the body. Cancer biomarkers are widely employed in the diagnosis and treatment of cancer patients. Biomarkers are employed in the follow-up surveillance and early diagnosis of suspected recurring diseases in cancer patients who have had curative surgery. In addition, the use of molecular biomarkers as part of normal diagnostic testing is a constant advancement in cancer diagnosis.
After skin cancer, breast cancer is the second most frequent type of cancer in the United States. Women are at a significant risk of developing breast cancer. Breast cancer is more common in women than in men, and male breast cancer is extremely rare. According to the Centers for Disease Control and Prevention (CDC), 236,968 women and 2,141 men were diagnosed with breast cancer in the United States in 2014, with 41,211 women and 465 men dying from the disease. According to 2015 figures from Cancer Research UK, new instances of breast cancer were diagnosed in the United Kingdom in 2015. Moreover, according to a comparable source, breast cancer is the most frequent cancer in the United Kingdom, accounting for a share of all new cancer cases in 2015.
According to the American Cancer Society, there were around 234,030 new instances of lung cancer diagnosed in the United States in 2018, with approximately 154,050 deaths attributable to lung cancer. Approximately 541,000 Americans have been diagnosed with lung cancer at a certain point in their life, as per the American Lung Association. Lung cancer has been diagnosed in the majority of patients in the last five years. In the United States, tens of thousands of people are treated for non-small cell lung cancer (NSCLC) each year. As a result of the rising prevalence of lung cancer, the Market is predicted to rise. This can be because of the region's higher usage of cancer biomarkers. Moreover, the region's high cancer incidence rate promotes Market expansion. In addition, in the region, numerous cancer biomarker testing is covered by health insurance. North America's supremacy can be ascribed to the larger adoption of modern technologies such as next-generation sequencing, as well as an increase in the number of research studies proving the efficacy of biomarkers in drug discovery and development, as well as cancer detection.
The US Market dominated the North America Cancer Biomarkers Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $8,674.7 million by 2028. The Canada Market is poised to grow at a CAGR of 18.1% during (2022 - 2028). Additionally, The Mexico Market would display a CAGR of 17% during (2022 - 2028).
Based on Profiling Technologies, the Market is segmented into Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, and Cytogenetics. Based on Application, the Market is segmented into Diagnostics, Research & Development, Prognostics, Risk Assessment, and Others. Based on Type, the Market is segmented into Protein, Genetic, and Others. Based on Cancer Type, the Market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Thyroid Cancer, Melanoma & Leukemia, Kidney & Bladder Cancer, Non-Hodgkin's Lymphoma, Prostate Cancer, and Others. Based on countries, the Market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Cancer Biomarkers Market is Estimated to reach $34.3 Billion by 2028, at a CAGR of 16.8%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Agilent Technologies, Inc., and Merck & Co., Inc.
Scope of the Study
Market Segments Covered in the Report:
By Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
By Application
- Diagnostics
- Research & Development
- Prognostics
- Risk Assessment
- Others
By Type
By Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Thyroid Cancer
- Melanoma & Leukemia
- Kidney & Bladder Cancer
- Non-Hodgkin's Lymphoma
- Prostate Cancer
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- BioMérieux S.A.
- F. Hoffmann-La Roche Ltd.
- Becton, Dickinson and Company
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Qiagen N.V.
- Agilent Technologies, Inc.
- Merck & Co., Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cancer Biomarkers Market, by Profiling Technologies
1.4.2 North America Cancer Biomarkers Market, by Application
1.4.3 North America Cancer Biomarkers Market, by Type
1.4.4 North America Cancer Biomarkers Market, by Cancer Type
1.4.5 North America Cancer Biomarkers Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Cancer Biomarkers Market
Chapter 4. North America Cancer Biomarkers Market by Profiling Technologies
4.1 North America Omics Technologies Market by Country
4.2 North America Imaging Technologies Market by Country
4.3 North America Immunoassay Market by Country
4.4 North America Bioinformatics Market by Country
4.5 North America Cytogenetics Market by Country
Chapter 5. North America Cancer Biomarkers Market by Application
5.1 North America Diagnostics Market by Country
5.2 North America Research & Development Market by Country
5.3 North America Prognostics Market by Country
5.4 North America Risk Assessment Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Cancer Biomarkers Market by Type
6.1 North America Protein Market by Country
6.2 North America Genetic Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Cancer Biomarkers Market by Cancer Type
7.1 North America Breast Cancer Market by Country
7.2 North America Lung Cancer Market by Country
7.3 North America Colorectal Cancer Market by Country
7.4 North America Thyroid Cancer Market by Country
7.5 North America Melanoma & Leukemia Market by Country
7.6 North America Kidney & Bladder Cancer Market by Country
7.7 North America Non-Hodgkin's Lymphoma Market by Country
7.8 North America Prostate Cancer Market by Country
7.9 North America Others Market by Country
Chapter 8. North America Cancer Biomarkers Market by Country
8.1 US Cancer Biomarkers Market
8.1.1 US Cancer Biomarkers Market by Profiling Technologies
8.1.2 US Cancer Biomarkers Market by Application
8.1.3 US Cancer Biomarkers Market by Type
8.1.4 US Cancer Biomarkers Market by Cancer Type
8.2 Canada Cancer Biomarkers Market
8.2.1 Canada Cancer Biomarkers Market by Profiling Technologies
8.2.2 Canada Cancer Biomarkers Market by Application
8.2.3 Canada Cancer Biomarkers Market by Type
8.2.4 Canada Cancer Biomarkers Market by Cancer Type
8.3 Mexico Cancer Biomarkers Market
8.3.1 Mexico Cancer Biomarkers Market by Profiling Technologies
8.3.2 Mexico Cancer Biomarkers Market by Application
8.3.3 Mexico Cancer Biomarkers Market by Type
8.3.4 Mexico Cancer Biomarkers Market by Cancer Type
8.4 Rest of North America Cancer Biomarkers Market
8.4.1 Rest of North America Cancer Biomarkers Market by Profiling Technologies
8.4.2 Rest of North America Cancer Biomarkers Market by Application
8.4.3 Rest of North America Cancer Biomarkers Market by Type
8.4.4 Rest of North America Cancer Biomarkers Market by Cancer Type
Chapter 9. Company Profiles
9.1 BioMérieux S.A.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.6 SWOT Analysis
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Qiagen N.V.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Product Launches and Product Expansions:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Merck & Co., Inc. (Merck Millipore)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
TABLE 1 North America Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 2 North America Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 3 North America Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 4 North America Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 5 North America Omics Technologies Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Omics Technologies Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Imaging Technologies Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Imaging Technologies Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Bioinformatics Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Bioinformatics Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Cytogenetics Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Cytogenetics Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 16 North America Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 17 North America Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Research & Development Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Research & Development Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Prognostics Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Prognostics Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Risk Assessment Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Risk Assessment Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 28 North America Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 29 North America Protein Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Protein Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Genetic Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Genetic Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 36 North America Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 37 North America Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Colorectal Cancer Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Colorectal Cancer Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Thyroid Cancer Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Thyroid Cancer Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Melanoma & Leukemia Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Melanoma & Leukemia Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Kidney & Bladder Cancer Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Kidney & Bladder Cancer Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Non-Hodgkin's Lymphoma Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Non-Hodgkin's Lymphoma Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Cancer Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Cancer Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 57 US Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 58 US Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 59 US Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 60 US Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 61 US Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 62 US Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 63 US Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 64 US Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 65 US Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 66 US Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 67 Canada Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 68 Canada Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 69 Canada Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 70 Canada Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 71 Canada Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 72 Canada Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 73 Canada Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 74 Canada Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 75 Canada Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 76 Canada Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 77 Mexico Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 78 Mexico Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 79 Mexico Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 80 Mexico Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 81 Mexico Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 82 Mexico Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 83 Mexico Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 84 Mexico Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 85 Mexico Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 86 Mexico Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 87 Rest of North America Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 88 Rest of North America Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 89 Rest of North America Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 90 Rest of North America Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 91 Rest of North America Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 92 Rest of North America Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 93 Rest of North America Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 94 Rest of North America Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 95 Rest of North America Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 96 Rest of North America Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 97 Key information – BioMérieux S.A.
TABLE 98 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 99 Key information – Becton, Dickinson and Company
TABLE 100 Key Information – Abbott Laboratories
TABLE 101 Key Information – Thermo Fisher Scientific, Inc.
TABLE 102 key information – Illumina, Inc.
TABLE 103 Key Information – Bio-Rad Laboratories, Inc.
TABLE 104 Key Information – Qiagen N.V.
TABLE 105 key Information – Agilent Technologies, Inc.
TABLE 106 KEY INFORMATION - MERCK & CO., INC.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 3 Swot analysis: thermo fisher scientific, inc.